{
  "scenario_id": "pharma_personalized_medicine_2025",
  "context": "Large pharmaceutical company, 10,000 employees, implementing personalized medicine platform",
  "stakeholders": {
    "requester": "Chief Scientific Officer",
    "approvers": ["CEO", "Chief Medical Officer", "CFO"],
    "influencers": ["VP R&D", "VP Commercial", "Data Privacy Officer"]
  },
  "request": {
    "amount": "$180,000,000",
    "purpose": "Develop and deploy personalized medicine platform using genomic data and AI",
    "urgency": "medium",
    "justification": "Competitive advantage in precision medicine market with 25% efficiency improvement in drug development"
  },
  "decision_process": [
    {
      "stage": "technology_evaluation",
      "duration": "4 months",
      "activities": ["Genomic sequencing technology assessment", "AI platform evaluation", "Data integration analysis"],
      "outcome": "Selected leading genomic and AI technologies"
    },
    {
      "stage": "pilot_program",
      "duration": "6 months",
      "activities": ["Clinical trial design", "Patient recruitment", "Data privacy framework development"],
      "outcome": "Successful pilot with 40% improvement in treatment outcomes"
    },
    {
      "stage": "full_scale_implementation",
      "duration": "12 months",
      "activities": ["Platform deployment", "Staff training", "Regulatory compliance"],
      "outcome": "Platform fully operational across major therapeutic areas"
    }
  ],
  "business_impact": {
    "expected_revenue": "$500,000,000 annually",
    "projected_efficiency_gain": "30% reduction in failed clinical trials",
    "risk_factors": ["Data privacy concerns", "Regulatory hurdles", "Technology integration challenges", "High development costs"]
  }
}